Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,651 | -14,195 | -8,748 | -5,107 | -2,244 |
| Depreciation Amortization | 8 | 18 | 12 | 6 | N/A |
| Other Working Capital | -741 | 3,338 | 1,158 | 371 | 79 |
| Other Operating Activity | 294 | 789 | 7,487 | 3,983 | 4,467 |
| Operating Cash Flow | $-4,090 | $-10,050 | $-91 | $-747 | $2,302 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -25,433 | 9,067 | N/A | N/A | N/A |
| PPE Investments | -2 | -64 | -62 | -60 | -45 |
| Other Investing Activity | -90 | -223 | -136 | -87 | -38 |
| Investing Cash Flow | $-25,525 | $8,780 | $-198 | $-147 | $-83 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 33,071 | 241 | 241 | 203 | 203 |
| Financing Cash Flow | $33,071 | $241 | $241 | $203 | $203 |
| Beginning Cash Position | 1,136 | 2,165 | 2,165 | 2,165 | 2,165 |
| End Cash Position | 4,592 | 1,136 | 2,117 | 1,474 | 4,587 |
| Net Cash Flow | $3,456 | $-1,029 | $-48 | $-691 | $2,422 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,090 | -10,050 | -91 | -747 | 2,302 |
| Capital Expenditure | -2 | -64 | -62 | -60 | -45 |
| Free Cash Flow | -4,092 | -10,114 | -153 | -807 | 2,257 |